- Report
- March 2025
- 147 Pages
Global
From €3485EUR$3,999USD£3,026GBP
- Report
- January 2026
- 475 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- January 2026
- 402 Pages
Global
From €5097EUR$5,850USD£4,427GBP
- Report
- January 2026
- 191 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- January 2026
- 196 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- January 2026
- 184 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- January 2026
- 186 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- November 2025
- 188 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- August 2025
- 182 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- August 2025
- 196 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- August 2025
- 189 Pages
Global
From €3432EUR$3,939USD£2,981GBP
- Report
- September 2025
- 250 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- January 2026
- 185 Pages
Global
From €3921EUR$4,500USD£3,405GBP
- Report
- January 2026
- 180 Pages
Global
From €3921EUR$4,500USD£3,405GBP
- Report
- November 2025
- 182 Pages
Global
From €3921EUR$4,500USD£3,405GBP
- Report
- August 2025
- 185 Pages
Global
From €3921EUR$4,500USD£3,405GBP
- Report
- June 2025
- 185 Pages
Global
From €3921EUR$4,500USD£3,405GBP
- Report
- December 2025
- 250 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- October 2025
- 250 Pages
Global
From €3912EUR$4,490USD£3,397GBP
- Report
- October 2025
- 250 Pages
Global
From €3912EUR$4,490USD£3,397GBP

Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It is a major public health concern, particularly in developing countries, and is the leading cause of death from a single infectious agent. TB is typically diagnosed through a combination of clinical symptoms, chest X-rays, and laboratory tests. Infectious disease testing for TB is used to detect the presence of the bacteria in a patient's sample. Tests may include sputum smear microscopy, culture, and nucleic acid amplification tests.
The TB testing market is expected to grow due to increasing prevalence of TB, rising awareness of TB diagnosis, and technological advancements in TB testing. The market is segmented by product type, end user, and geography.
Companies in the TB testing market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more